Status: current, Sufficiently defined by necessary conditions definition status. Date: 28-Feb 2022. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4695255015 | Penicillin G benzathine 1.2 million unit powder for suspension for injection vial | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
4695256019 | Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
4695257011 | Benzathine benzylpenicillin 1.2 million unit powder for suspension for injection vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug) | Is a | Product containing only benzylpenicillin in parenteral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug) | Has manufactured dose form | Powder for conventional release suspension for injection | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug) | Has unit of presentation | Vial | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug) | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug) | Has precise active ingredient | Benzathine benzylpenicillin | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug) | Has basis of strength substance | Benzathine benzylpenicillin | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug) | Has presentation strength numerator unit | Million unit | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug) | Has presentation strength denominator unit | Vial | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug) | Is a | Product containing only benzathine benzylpenicillin in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets